cerrar
Tagged with Rare disease

A New Paradigm for Rare Diseases in China
Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the potential to lead the global…

Eric Björnestål – General Manager, Grifols Nordic
Grifols is a pioneer in plasma science that develops plasma into essential medicines used to treat rare, chronic and life-threatening conditions. Eric…

Olav Fromm – Managing Director, Chiesi Nordics
Olav Fromm, managing director of Chiesi Nordics, explains the deep roots of Chiesi in Sweden, where its blockbuster drug, a surfactant for treating…

Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape, Irish-headquartered rare disease…

How US Healthcare Can Better Accommodate Cell & Gene…
PhRMA's Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in recent years and the three ways in which the…

Hardy Chan – Chairman and President, Allianz Pharmascience,…
Dr Hardy Chan shares the story of how he came out of retirement to lead Allianz Pharmascience; an up-and-coming biotech which aims to meet the unmet…

Mattias Bankel – General Manager, Head of Nordics &…
Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases.…

Stefanie Granado – Director General Iberia, Takeda
Stefanie Granado, director general of Takeda Iberia recounts the opportunities available for Takeda in Spain following its acquisition of Shire. She…

Taming the ‘Wild West’ of CBD
Monica Weldon looks at the history of medicinal CBD, its current usages in the USA, and why robust scientific research on its efficacy need to be…

Ines Perea – General Manager, Jazz Pharmaceuticals Spain…
Ines Perea, general manager for Spain and Portugal at Jazz Pharmaceuticals, a global biopharmaceutical company dedicated to developing life-changing…

Franck Cousserans – General Manager France & Belgium,…
Franck Cousserans, general manager of France and Belgium at Jazz Pharmaceuticals, highlights the company’s key products and the challenges of market…

Amryt: A Rare Disease Startup Going Global
Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial asset on the market, a strong…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here